Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

Head & Neck Oncology

Open Access

Methicillin Resistant Staphylococcus Aureus Infection as a causative agent of fistula formation following total laryngectomy for advanced head & neck cancer

  • Jean-Pierre Jeannon1Email author,
  • Ahmad Orabi1,
  • Argyris Manganaris1 and
  • Ricard Simo1
Head & Neck Oncology20102:14

https://doi.org/10.1186/1758-3284-2-14

Received: 24 February 2010

Accepted: 28 June 2010

Published: 28 June 2010

Abstract

Aims

The purpose of this paper was to investigate the impact of Methicillin Resistant Staphylococcus Aureus (MRSA) infection in the aetiology of pharyngo-cutaneous fistula (PCF) formation following total laryngectomy for advanced laryngeal cancer.

Methods

This was a retrospective uncontrolled case study series of 31 consecutive patients based in a single institution tertiary referral head and neck oncology centre.

Results

Pharyngo-cutaneous fistulas (PCF) following total laryngectomy occurred in 10 (32%) patients. MRSA was identified in 80% of patients with a PCF compared to 9% of patients that did not develop a fistula (p = 0.0001255 Fisher exact test). MRSA infection (p = 0.00012) and previous radiotherapy (p = 0.00025) were the only significant factors found to be important in fistula formation on multivariate analysis. Post-operative infections such as cellulitis, chest infection and carotid fistula were also associated with MRSA infections.

Conclusion

MRSA infection following total laryngectomy for laryngeal cancer can lead to potential serious complications such as PCF. Patients who underwent total laryngectomy following radiotherapy failure are at a higher risk of acquiring MRSA.

Introduction

Total laryngectomy is a major surgical procedure used to treat advanced cancer of the larynx.

Pharyngo-cutaneous fistula (PCF) is a complex type of wound dehiscence and hence a potential major complication following total laryngectomy. The reported incidence of this complication following laryngectomy varies between 8-40% [1]. It results when a pathological communication develops between the internal mucosa of the pharynx and the external skin which discharges saliva (Figure 1). The immediate sequelae of PCF is that oral feeding has to be suspended. This delays healing in the post-operative period and the subsequent loss of fluids, electrolytes and proteins in the fistula further compromises the patient's condition. Long-term problems following PCF may include aspiration, further wound infection, chest infection and cachexia.
Figure 1

Photograph showing large PCF 10 days post SL with heavy growth of MRSA.

The aetiology of PCF is thought to be multi-factorial [1]. Several factors have been thought to be important and can be generally divided into patient factors and operative factors. In particular these can include pre-operative co-morbidity, pre-operative radiotherapy, peri-operative wound infection, advanced T stage and closure technique.

Methicillin Resistant Staphylococcus Aureus (MRSA) infection in the post-surgical patient is associated with higher post-operative morbidity including skin breakdown and cellulitis [2]. No previous study has investigated MRSA infection as a causative factor in PCF following laryngectomy.

The objective of this paper is to review our experience of patients who have developed PCF following total laryngectomy and determine the influence of MRSA is a causative factor.

'What is already known about this topic?

The aetiology of pharyngo-cutaneous fistula (PCF) is thought to be multifactorial. MRSA infection is associated with higher postoperative morbidity including skin breakdown and fistula formation. No previous study has investigated MRSA infection as a causative factor in PCF following laryngectomy.

'What does this article add?

This is the first study to identify MRSA as a possible causative agent in PCF following laryngectomy. Implementation of MRSA eradication protocol is recommended in every patient undergoing laryngectomy.

Material and Methods

This is a retrospective review of 31 consecutive patients who underwent total laryngectomy at Guy's & St Thomas NHS Foundation Trust London, which is the tertiary regional cancer centre for the South East London Head and Neck Cancer Network (SELCN). The study period ran from January 2004 until January 2007. From January 2004 all patients undergoing treatment for head and neck cancer have been entered prospectively on a database.

All patients with a diagnosis of head and neck cancer were discussed in the regional head and neck oncology multidisciplinary team (MDT) meeting prior to definitive treatment being commenced.

Patients underwent elective pre-admission MRSA screening upon admission through swab taking. Subsequent screening continued throughout the in patient stay in hospital. Therefore all new MRSA acquisitions were therefore detected prospectively. During their inpatient stay as a routine protocol, patients were screened for MRSA twice weekly.

Patient data including MRSA swab results and post-operative water soluble swallow tests were retrieved from the electronic patient record.

All patients undergoing head and neck surgery were given peri-operative antibiotic prophylaxis and post-operative gastro-oesophageal reflux medication as a protocol.

For the purpose of this study a pharyngo-cutaneous fistula was defined as a clinically detected fistula or radiologically identified leak that delayed the onset of oral feeding after laryngectomy.

Multivariate analysis was performed using STATA statistical software to analyse the data. The following factors were analysed to determine their effect on fistula formation: T stage, previous radiotherapy and MRSA infection.

Ethical Considerations

Data was retrieved from the database using medical record numbers hence patients remained anonymous. Ethical approval was not needed for this study.

Results

During the study period (2004 to 2007 inclusive), 31 total laryngectomies were performed for advanced laryngeal cancer.

The patient demographic data were illustrated in Table 1. The mean patient age was 65 years (range 37 to 86).
Table 1

Patient Demographic Data

Patient

TNM

PREVIOUS RADIOTHERAPY

MRSA

FISTULA

1

T4N0M0

N

X

X

2

T2N0M0

Y

3

T4N1M0

N

X

X

4

T2N0M0

Y

X

5

T4N0M0

Y

X

X

6

T3N2BM0

N

X

X

7

T4N1M0

N

X

X

8

T3N2BM0

N

X

X

9

T4N0M0

N

10

T4N0M0

N

11

T3N1M0

N

X

X

12

T4N2CM0

N

X

X

13

T3N2CM0

Y

14

T4N0M0

N

X

X

15

T3N0M0

Y

16

T2N0M0

Y

X

17

T2N0M0

Y

X

X

18

T4N0M0

N

X

X

19

T3N0M0

Y

20

T4N1M0

Y

21

T2N0M0

Y

X

X

22

T4N0M0

Y

X

23

T4N2BM0

N

X

X

24

T3N0M0

Y

X

X

25

T3N1M0

N

X

X

26

T2N0M0

Y

X

X

27

T2N2BM0

N

28

T2N0M0

Y

X

X

29

T2N0M0

Y

X

X

30

T3N2BM0

N

X

31

T2N0M0

Y

X

X

15 patients underwent primary laryngectomy for advanced laryngeal cancer and 16 patients had salvage laryngectomy for recurrence after previous failed radiotherapy.

A pharyngo-cutaneous fistula (PCF) occurred in 10 (32%) patients, MRSA was identified in 8 of these patients. Of the 21 patients that did not develop a PCF, 2 were found to acquire MRSA infection (in the tracheal stoma). This difference reached statistical significance p = 0.0001255 Fisher exact test (Table 2).
Table 2

MRSA Infection and Fistula Formation

 

FISTULA +VE

NO FISTULA

TOTAL

MRSA +VE

8

2

10

MRSA -VE

2

19

21

TOTAL

10

21

31

(p = 0.0001255 Fisher exact test)

None of these 31 patients were found to be carriers of MRSA on pre-operative screening. Therefore from this group of 31 patients, 10 (32%) were seen to acquire MRSA during their hospital stay.

Using multivariate analysis, previous radiotherapy (p = 0.00025) and MRSA infection (p = 0.00012) were identified as significant risk factors for PCF (Table 3).
Table 3

Multivariate analysis of Risk Factors for PCF

 

pVALUE

ODDS RATIO

CONFIDENCE INTERVAL

T STAGE

p = 0.054

1.15

0.4 - 4.5

MRSA INFECTION

p = 0.00012

9.2

2.36-35.8

PREVIOUS RADIOTHERAPY

p = 0.00025

8.6

1.24-27.9

(Log rank test)

MRSA was cultured from the tracheostomy stoma site in 5 patients, in 3 patients it was detected in the fistula site, from the surgical drain 1 and from the gastrostomy site in 1 patient (Figure 2).
Figure 2

Sites where MRSA was isolated.

The 2 patients that did acquire MRSA but did not develop PCF did however suffer significant morbidity. 1 patient developed a significant cellulitis infection and 1 had a carotid fistula that required return to the operating theatre to arrest the bleeding.

Discussion

MRSA may reside in healthy individuals and not cause any health problems. However hospital acquired infection can result in significant morbidity and mortality. The first case of MRSA was identified as early as 1961- 1962 shortly after introduction of Methicillin in 1960 [24]. MRSA has caused particular concern due to the resistance to standard antibiotics caused by gene mecA and the rapidity with which it spreads [25]. MRSA arose as a hospital based infection but has steadily spread to the community [4, 5]. Hospital acquired MRSA infection has been steadily increasing and in some reports infection rates have reached over 60% [4]. In this series we have identified an acquisition rate of 30% which is high. We believe this is because head and neck patients undergoing major surgery particularly at risk of this infection.

Head and neck cancer patients are prone to MRSA infection due to a number of factors such as: prolonged hospitalization, intravascular catheterization, compromised host immunity, malignancy, chemotherapy, radiotherapy surgery, prior antibiotic therapy and prolonged operative time [27]. Many of these factors were present in our series of patients. Following total laryngectomy, the mucosa of the trachea is permanently directly exposed to room air and we feel this site is particularly prone to MRSA infection. This is why the tracheal stoma was shown to be the commonest site of infection.

Serious postoperative complications related to MRSA infection have been identified in head and neck surgery patients with significant increase in morbidity [8, 9] number of surgical procedures and prolonged hospitalization time [10]. One of our patients had a carotid fistula or 'blow out' which is a life threatening complication. Colonisation of the tracheostomy site appeared to be the most important site of MRSA infection. The creation of a permanent tracheostomy following total laryngectomy may significantly reduce the patient's local defence mechanism allowing a conduit of infection to the aero-digestive tract.

PCF following laryngectomy constitutes a particularly serious complication with subsequent devastating medical, functional, psychological and economical effects. The rate ranges considerably from 8% to 40%, according to the literature [1117]. A recently published meta-analysis of previously published studies on post-laryngectomy PCF concluded that the following four factors were thought to be significant: a) preoperative radiotherapy, b) postoperative haemoglobin level below 12.5 g/dl, c) prior tracheostomy, and d) preoperative radiotherapy and concurrent neck dissection [1]. Our study also has identified pre-operative radiotherapy as an important risk factor for PCF.

To our knowledge this is the first study to investigate and suggest a potential causal relationship between PCF and MRSA in patients undergoing total laryngectomy for laryngeal cancer. Whilst we have found a significantly higher MRSA infection rate in patients that have developed PCF following laryngectomy compared to those that did not, this association only implicates MRSA as a possible causative factor in. We recognise the limitations of this paper in that the design is retrospective and sample size small, however we feel the high incidence of MRSA infection seen in the PCF patients warrants further study.

The incidence of PCF in our laryngectomy patients was high (32%) compared to previously published series. The focus of future study in our institution is aimed at reducing this PCF rate.

MRSA principal mode of transmission is through direct contact via hospital personnel and by airborne transmission particularly from patients with tracheostomies [26]. Many strategies have been advocated to prevent MRSA infection with variable degree of evidence based, including search and destroy policy, restrictive antibiotic prescribing policy [12], hand hygiene with the use of alcohol- based solutions, isolation measures [13]. The high incidence of MRSA infection seen in this patient group obliged us to upgrade our infection control protocols and we have subsequently seen a dramatic reduction in MRSA infection rates.

There is some controversy regarding treating MRSA colonization versus infection particularly in hospital staff carriers and in endemic areas like UK, which can be proved to be difficult. However because of the particular risks associated with head and neck cancer patients, colonized patients should be eradicated prior to major surgery [10]. The current approach is to carry out preoperative screening and appropriate treatment by antiseptic skin washes, nasal mupirocin and chlorhexadine mouthwashes, isolation or barrier nursing and perioperative anti MRSA antibiotic in carrier patients, and judicious antibiotic prescription practice.

Having carried out this study, we have implemented an MRSA eradication protocol in all patients undergoing laryngectomy even if they are not colonized with MRSA in order to reduce infection rates. We have also seen a significant overall reduction in MRSA infection rates across the hospital due to strict hand hygiene, screening and MRSA eradication protocols being implemented.

MRSA will continue to pose a challenge because of rising incidence not only in hospitals and nursing homes but also in the outpatient community. The emergence of increasingly resistant staph. aureus organisms and the demand to treat patients with more and more complex medical conditions will continue to test medical and nursing staff in the future.

Conclusion

This is the first study to identify MRSA as a possible causative agent in pharyngo-cutaneous fistula (PCF) following total laryngectomy for laryngeal cancer. Patients who underwent laryngectomy following radiotherapy failure and acquired MRSA were at higher risk of PCF. MRSA infection post laryngectomy can lead to significant morbidity. A multidisciplinary approach is essential for effective management. Implementation of MRSA eradication protocol is recommended in every patient undergoing salvage laryngectomy.

Conflict of interest

The authors declare that they have no competing interests.

Declarations

Acknowledgements

None

Disclosure

The authors state that they have no interests which might be perceived as posing a conflict or bias.

Authors’ Affiliations

(1)
Department of Ear Nose & Throat - Head and Neck Surgery, Guy's and St Thomas' Hospital NHS Foundation Trust

References

  1. Paydarfar JA, Birkmeyer NJ: Complications in head and neck surgery: a meta-analysis of postlaryngectomy pharyngocutaneous fistula. Arch Otolaryngol Head Neck Surg. 2006, 132 (1): 67-72. 10.1001/archotol.132.1.67.View ArticlePubMedGoogle Scholar
  2. Watters K, O'dwyer TP, Rowley H: Cost and morbidity of MRSA in head and neck cancer patients: what are the consequences?. J Laryngol Otol. 2004, 118: 694-9. 10.1258/0022215042244732.View ArticlePubMedGoogle Scholar
  3. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5: 649-655. 10.1097/00000421-198212000-00014.View ArticlePubMedGoogle Scholar
  4. Nixon IJ, Bingham BJG: The impact of methicillin-resistant staphylococcus aureus on ENT practice. J Laryngol Otol. 2006, 112: 713-7.Google Scholar
  5. Collins M, Tami TA: Methicillin-resistant Staphylococcus aureus (MRSA) in the practice of otolaryngology - an emerging community acquired organism?. Curr Opin Otolaryngol Head Neck Surg. 2003, 11: 179-83. 10.1097/00020840-200306000-00009.View ArticlePubMedGoogle Scholar
  6. Shiomori T, Miyamoto H, Udaka T, Okochi J, Hiraki N, et al: Clinical features of head and neck cancer patients with methicillin-resistant Staphylococcus aureus. Acta Oto-Laryngologica. 2007, 127: 180-185. 10.1080/00016480600750018.View ArticlePubMedGoogle Scholar
  7. Morimoto Y, Sugiura T, Tatebayashi S, Kirita T: Reduction in incidence of methicillin-resistant Staphylococcus aureus (MRSA) after radical surgery for head and neck cancer. Spec Care Dentist. 2006, 26: 209-13. 10.1111/j.1754-4505.2006.tb01440.x.View ArticlePubMedGoogle Scholar
  8. Parton M, Beasley NJP, Harvey G, Houghton D, Jones AS: Four cases of aggressive MRSA wound infection following head and neck surgery. J Laryngol Otol. 1997, 3: 874-6.Google Scholar
  9. Tungekar MF: Tracheocarotid artery fistula infected with methicillin resistant Staphylococcus aureus. J Laryngol Otol. 1999, 113: 689-91. 10.1017/S0022215100144871.View ArticlePubMedGoogle Scholar
  10. Simo R, French G: The use of prophylactic antibiotics in head and neck oncological surgery. Curr Opin Otolaryngol Head Neck Surg. 2006, 14: 55-61. 10.1097/01.moo.0000193183.30687.d5.View ArticlePubMedGoogle Scholar
  11. Stoeckli SJ, Pawlik AB, Lipp M, Huber A, Schmid S: Salvage Surgery After Failure of Nonsurgical Therapy for Carcinoma of the Larynx and Hypopharynx. Arch Otolaryngol Head Neck Surg. 2000, 126: 1473-7.View ArticlePubMedGoogle Scholar
  12. Watters GWR, Patel SG, Rhys-Evans PH: Partial laryngectomy for recurrent laryngeal carcinoma. Clin Otolaryngol. 2000, 25: 146-152. 10.1046/j.1365-2273.2000.00333.x.View ArticlePubMedGoogle Scholar
  13. Nibu K, Kamata S, Kawabata K, et al: Partial laryngectomy in the treatment of radiation failure of early glottic carcinoma. Head Neck. 1997, 19: 116-120. 10.1002/(SICI)1097-0347(199703)19:2<116::AID-HED5>3.0.CO;2-7.View ArticlePubMedGoogle Scholar
  14. Ganly I, Patel SG, Matsuo J, et al: Results of Surgical Salvage after Failure of Definitive Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx. Arch Otolaryngol Head Neck Surg. 2006, 132: 59-66. 10.1001/archotol.132.1.59.View ArticlePubMedGoogle Scholar
  15. Ganly I, Patel S, Matsuo J, et al: Postoperative complications of salvage total laryngectomy. Cancer. 2005, 103: 2073-81. 10.1002/cncr.20974.View ArticlePubMedGoogle Scholar
  16. Wertheim HF, Vos MC, Boelens HA, Voss A: Vandenbroucke-Grauls CM, Meester MH et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) athospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004, 56: 321-5. 10.1016/j.jhin.2004.01.026.View ArticlePubMedGoogle Scholar
  17. Voss A: Preventing the spread of MRSA. BMJ. 2004, 329 (7465): 521-10.1136/bmj.329.7465.521.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Jeannon et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement